Earnings Feed
Start Free
Home/Filings/4/0001181431-13-056999
4//SEC Filing

HARVARD BIOSCIENCE INC 4

Accession 0001181431-13-056999

$HBIOCIK 0001123494operating
View on SEC.govCompany Profile

Filed

Nov 4, 7:00 PM ET

Accepted

Nov 5, 6:20 PM ET

Size

24.1 KB

Accession

0001181431-13-056999

Insider Transaction Report

Form 4
Period: 2013-11-01
HARVARD BIOSCIENCE INCHBIO
LUSCINSKI SUSAN M
Chief Operating Officer
Transactions
  • Other

    Stock option (right to buy)

    2013-11-01+19,799→ 87,774 total
    Exercise: $3.07Exp: 2016-08-09→ Common Stock, par value $0.01 per share (19,799 underlying)
  • Other

    Stock option (right to buy)

    2013-11-01+11,806→ 49,028 total
    Exercise: $3.64Exp: 2023-05-31→ Common Stock, par value $0.01 per share (11,806 underlying)
  • Other

    Common Stock

    2013-11-01+24,201→ 469,720 total
  • Other

    Stock option (right to buy)

    2013-11-01+35,757→ 135,757 total
    Exercise: $5.73Exp: 2014-03-25→ Common Stock, par value $0.01 per share (35,757 underlying)
  • Other

    Stock option (right to buy)

    2013-11-01+11,996→ 49,496 total
    Exercise: $2.14Exp: 2015-05-25→ Common Stock, par value $0.01 per share (11,996 underlying)
  • Other

    Stock option (right to buy)

    2013-11-01+31,723→ 131,723 total
    Exercise: $3.99Exp: 2017-05-01→ Common Stock, par value $0.01 per share (31,723 underlying)
  • Other

    Stock option (right to buy)

    2013-11-01+48,543→ 201,296 total
    Exercise: $2.28Exp: 2019-05-21→ Common Stock, par value $0.01 per share (48,543 underlying)
  • Other

    Stock option (right to buy)

    2013-11-01+11,888→ 49,388 total
    Exercise: $4.04Exp: 2021-06-02→ Common Stock, par value $0.01 per share (11,888 underlying)
  • Other

    Stock option (right to buy)

    2013-11-01+25,098→ 104,135 total
    Exercise: $2.56Exp: 2022-06-01→ Common Stock, par value $0.01 per share (25,098 underlying)
Footnotes (10)
  • [F1]These additional options and restricted stock units were acquired by the Reporting Person in connection with the adjustment to the existing options and restricted stock units held by the Reporting Person and required in connection with the spin-off of Harvard Apparatus Regenerative Technology, Inc. by the Issuer. As part of such required adjustment relating to the spin-off, the exercise price of the options underlying these adjustment option grants was also reset to the exercise price of these adjustment grants to reflect the impact of the spin-off. The share amounts and exercise prices of the adjusted options and restricted stock units were set in a manner to ensure the intrinsic value held by the Reporting Person pertaining to the existing award was maintained immediately following the spin-off. In addition to these adjustments, to maintain such intrinsic value, equity awards issued by Harvard Apparatus Regenerative Technology, Inc. were also granted to the Reporting Person.
  • [F10]The unvested shares become exercisable in equal installments on January 1 of each of 2014, 2015, 2016 and 2017.
  • [F2]Includes (a) an adjusted deferred stock award of 21,992 restricted stock units which shall vest on Jan 1, 2014; (b) an adjusted deferred stock award of 12,347 restricted stock units which vest in equal installments on Jan 1, 2014 and Jan 1, 2015; (c) an adjusted deferred stock award of 40,764 restricted stock units which vest in equal installments on Jan 1, 2014, Jan 1, 2015, and Jan 1, 2016; (d) an adjusted deferred stock award of 25,465 restricted stock units which vest in equal installments on Jan 1, 2014, Jan 1, 2015, Jan 1, 2016, and Jan 1, 2017; and (e) 369,152 shares of common stock held by the Reporting Person.
  • [F3]The option shares vested in four equal installments on January 1, 2005, 2006, 2007 and 2008.
  • [F4]The option shares vested in four equal installments on January 1, 2006, 2007, 2008 and 2009.
  • [F5]The option shares vested in four equal installments on January 1, 2007, 2008, 2009 and 2010.
  • [F6]The option shares vested in four equal installments on January 1, 2008, 2009, 2010 and 2011.
  • [F7]The option shares vested in four equal installments on January 1, 2010, 2011, 2012 and 2013
  • [F8]The unvested shares become exercisable in equal installments on January 1 of each of 2014 and 2015.
  • [F9]The unvested shares become exercisable in equal installments on January 1 of each of 2014, 2015 and 2016.

Documents

1 file

Issuer

HARVARD BIOSCIENCE INC

CIK 0001123494

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001123494

Filing Metadata

Form type
4
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 6:20 PM ET
Size
24.1 KB
View on SEC.gov